JP2022541740A5 - - Google Patents
Info
- Publication number
- JP2022541740A5 JP2022541740A5 JP2022500900A JP2022500900A JP2022541740A5 JP 2022541740 A5 JP2022541740 A5 JP 2022541740A5 JP 2022500900 A JP2022500900 A JP 2022500900A JP 2022500900 A JP2022500900 A JP 2022500900A JP 2022541740 A5 JP2022541740 A5 JP 2022541740A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- mrna
- independently
- lipid
- cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024194073A JP2025024002A (ja) | 2019-07-08 | 2024-11-06 | 改善されたｍＲＮＡ装填脂質ナノ粒子、およびそれを作製するプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871513P | 2019-07-08 | 2019-07-08 | |
| US62/871,513 | 2019-07-08 | ||
| PCT/US2020/041122 WO2021007278A1 (en) | 2019-07-08 | 2020-07-08 | Improved mrna-loaded lipid nanoparticles and processes of making the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024194073A Division JP2025024002A (ja) | 2019-07-08 | 2024-11-06 | 改善されたｍＲＮＡ装填脂質ナノ粒子、およびそれを作製するプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022541740A JP2022541740A (ja) | 2022-09-27 |
| JP2022541740A5 true JP2022541740A5 (https=) | 2023-06-30 |
| JP7586886B2 JP7586886B2 (ja) | 2024-11-19 |
Family
ID=71784731
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500900A Active JP7586886B2 (ja) | 2019-07-08 | 2020-07-08 | 改善されたｍＲＮＡ装填脂質ナノ粒子、およびそれを作製するプロセス |
| JP2024194073A Pending JP2025024002A (ja) | 2019-07-08 | 2024-11-06 | 改善されたｍＲＮＡ装填脂質ナノ粒子、およびそれを作製するプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024194073A Pending JP2025024002A (ja) | 2019-07-08 | 2024-11-06 | 改善されたｍＲＮＡ装填脂質ナノ粒子、およびそれを作製するプロセス |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230181483A1 (https=) |
| EP (2) | EP3996683B1 (https=) |
| JP (2) | JP7586886B2 (https=) |
| KR (1) | KR20220078557A (https=) |
| CN (2) | CN119454644A (https=) |
| AU (1) | AU2020311364B2 (https=) |
| CA (1) | CA3146369A1 (https=) |
| ES (2) | ES3064716T3 (https=) |
| WO (1) | WO2021007278A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3675817A1 (en) | 2017-08-31 | 2020-07-08 | Modernatx, Inc. | Methods of making lipid nanoparticles |
| US20230181483A1 (en) * | 2019-07-08 | 2023-06-15 | Translate Bio, Inc. | Improved mrna-loaded lipid nanoparticles and processes of making the same |
| JP2023508881A (ja) | 2019-12-20 | 2023-03-06 | トランスレイト バイオ， インコーポレイテッド | Ｍｒｎａ担持脂質ナノ粒子を調製する改善されたプロセス |
| WO2023009422A1 (en) * | 2021-07-26 | 2023-02-02 | Modernatx, Inc. | Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to airway epithelium |
| US20240398940A1 (en) | 2021-09-03 | 2024-12-05 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids |
| KR20230053998A (ko) | 2021-10-15 | 2023-04-24 | (주)지노믹트리 | mRNA 발현을 위한 유전자 구조체 |
| EP4422698A1 (en) | 2021-10-29 | 2024-09-04 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| US20250099614A1 (en) | 2022-01-28 | 2025-03-27 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| US20250345407A1 (en) | 2022-05-25 | 2025-11-13 | CureVac SE | Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide |
| US20260069713A1 (en) | 2022-08-29 | 2026-03-12 | Vivasor, Inc. | Lipid-Coated Nanoparticles |
| EP4608442A1 (en) | 2022-10-28 | 2025-09-03 | GlaxoSmithKline Biologicals S.A. | Nucleic acid based vaccine |
| WO2024184500A1 (en) | 2023-03-08 | 2024-09-12 | CureVac SE | Novel lipid nanoparticle formulations for delivery of nucleic acids |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
| EP4722368A1 (en) | 2023-05-26 | 2026-04-08 | Samsung Biologics Co., Ltd. | Novel nucleic acid construct comprising poly(a) tail having secondary or tertiary structure and uses thereof |
| KR20250018367A (ko) | 2023-07-28 | 2025-02-05 | 한국과학기술원 | 히스톤 코드 리더 도메인을 포함하는 폴리펩티드 및 이의 용도 |
| WO2025184508A1 (en) * | 2024-03-01 | 2025-09-04 | Acuitas Therapeutics, Inc. | Materials and methods for encapsulating therapeutics in lipid nanoparticles |
| CN121265551A (zh) * | 2024-07-02 | 2026-01-06 | 苏州星核迪赛生物技术有限公司 | 一种靶向肝实质细胞的核酸递送载体及其应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1580968A (en) | 1923-01-26 | 1926-04-13 | Brazza Ascanio Di | Firearm with screwed barrel detachable by hand or permanently fixed |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| FR2645866B1 (fr) | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
| US5334761A (en) | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| CA2569664C (en) | 2004-06-07 | 2013-07-16 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering rna |
| CA2740000C (en) | 2008-10-09 | 2017-12-12 | Tekmira Pharmaceuticals Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
| EP3269395A1 (en) | 2008-11-07 | 2018-01-17 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| KR101766408B1 (ko) | 2009-06-10 | 2017-08-10 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| EP3318248B1 (en) | 2009-12-01 | 2019-04-10 | Translate Bio, Inc. | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases |
| ES2795110T3 (es) | 2011-06-08 | 2020-11-20 | Translate Bio Inc | Lípidos escindibles |
| PE20181541A1 (es) | 2011-10-27 | 2018-09-26 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco |
| BR112014024131A2 (pt) | 2012-03-29 | 2017-07-25 | Shire Human Genetic Therapies | lipídios catiônicos ionizáveis |
| EP3083556B1 (en) | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| JP6557722B2 (ja) | 2014-05-30 | 2019-08-07 | シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド | 核酸の送達のための生分解性脂質 |
| HUE060907T2 (hu) | 2014-06-25 | 2023-04-28 | Acuitas Therapeutics Inc | Új lipidek és lipid nanorészecske formulációk nukleinsavak bevitelére |
| US9840479B2 (en) | 2014-07-02 | 2017-12-12 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
| BR112016030852A2 (pt) | 2014-07-02 | 2018-01-16 | Shire Human Genetic Therapies | encapsulação de rna mensageiro |
| EP3247363A4 (en) | 2015-01-21 | 2018-10-03 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| EP3247398A4 (en) | 2015-01-23 | 2018-09-26 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| WO2016205691A1 (en) | 2015-06-19 | 2016-12-22 | Massachusetts Institute Of Technology | Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell |
| PT3313829T (pt) | 2015-06-29 | 2024-07-08 | Acuitas Therapeutics Inc | Formulações de lípidos e de nanopartículas lipídicas para a administração de ácidos nucleicos |
| JP6948313B6 (ja) | 2015-09-17 | 2022-01-14 | モデルナティエックス インコーポレイテッド | 治療剤の細胞内送達のための化合物および組成物 |
| HRP20230209T1 (hr) | 2015-10-28 | 2023-04-14 | Acuitas Therapeutics Inc. | Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina |
| WO2017117528A1 (en) | 2015-12-30 | 2017-07-06 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| LT3436077T (lt) | 2016-03-30 | 2025-06-25 | Intellia Therapeutics, Inc. | Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams |
| EP3315125A1 (en) * | 2016-10-31 | 2018-05-02 | Silence Therapeutics (London) Ltd | Lipid nanoparticle formulation |
| CA3043033A1 (en) | 2016-11-10 | 2018-05-17 | Translate Bio, Inc. | Improved ice-based lipid nanoparticle formulation for delivery of mrna |
| AU2017357758B2 (en) * | 2016-11-10 | 2023-11-16 | Translate Bio, Inc. | Improved process of preparing mRNA-loaded lipid nanoparticles |
| MA47824A (fr) | 2017-03-07 | 2020-01-15 | Translate Bio Inc | Administration polyanionique d'acides nucléiques |
| EP3876914A2 (en) * | 2018-11-09 | 2021-09-15 | Translate Bio, Inc. | Messenger rna therapy for treatment of ocular diseases |
| AU2019376660B2 (en) * | 2018-11-09 | 2025-06-26 | Translate Bio, Inc. | 2,5-dioxopiperazine lipids with intercalated ester, thioester, disulfide and anhydride moieities |
| US20230181483A1 (en) * | 2019-07-08 | 2023-06-15 | Translate Bio, Inc. | Improved mrna-loaded lipid nanoparticles and processes of making the same |
-
2020
- 2020-07-08 US US17/625,507 patent/US20230181483A1/en active Pending
- 2020-07-08 EP EP20745451.3A patent/EP3996683B1/en active Active
- 2020-07-08 AU AU2020311364A patent/AU2020311364B2/en active Active
- 2020-07-08 CN CN202411475913.9A patent/CN119454644A/zh active Pending
- 2020-07-08 CN CN202080062330.7A patent/CN114390921B/zh active Active
- 2020-07-08 KR KR1020227004274A patent/KR20220078557A/ko active Pending
- 2020-07-08 CA CA3146369A patent/CA3146369A1/en active Pending
- 2020-07-08 ES ES24189330T patent/ES3064716T3/es active Active
- 2020-07-08 ES ES20745451T patent/ES2992127T3/es active Active
- 2020-07-08 JP JP2022500900A patent/JP7586886B2/ja active Active
- 2020-07-08 EP EP24189330.4A patent/EP4467653B1/en active Active
- 2020-07-08 WO PCT/US2020/041122 patent/WO2021007278A1/en not_active Ceased
-
2024
- 2024-11-06 JP JP2024194073A patent/JP2025024002A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541740A5 (https=) | ||
| JP2025024002A5 (https=) | ||
| KR101352490B1 (ko) | 신규 리포좀 조성물 | |
| JP2022542562A5 (https=) | ||
| Wang et al. | Doxorubicin conjugated phospholipid prodrugs as smart nanomedicine platforms for cancer therapy | |
| JP6689378B2 (ja) | 巨大分子の経口送達のための細胞浸透性ペプチド及びテトラエーテル脂質を含むリポソーム | |
| CN107708671B (zh) | 包含钴卟啉-磷脂缀合物和聚组氨酸标签的纳米结构 | |
| US20090110739A1 (en) | Targeted cancer chemotherapy using synthetic nanoparticles | |
| JP2024059777A (ja) | ポリシアル酸および／またはその他のポリマーを含む薬物送達のシステムおよび方法 | |
| KR20100129749A (ko) | 치료, 진단과 실험적 혼합물들의 운반을 위한 공학적으로 가변된 나노입자 및 치료용 관련 조성물 | |
| JP2024546431A5 (https=) | ||
| CN105496961A (zh) | 适配体靶向脂质体载药系统及制备方法和应用 | |
| JP7821776B2 (ja) | 効率的な核酸送達のための担体 | |
| CN102781427B (zh) | 易崩解型聚合物微团组合物 | |
| JP2022502392A (ja) | 経口剤形の製造方法 | |
| JP2004527585A (ja) | 脂質−ポリマー結合体 | |
| US20230398077A1 (en) | Silicasome nanocarrier for metal-based drug delivery | |
| CN114080412A (zh) | 蛋白质内包高分子胶束 | |
| JP2020515648A (ja) | リポソーム組成物及びそれを含む固体経口剤形 | |
| Li et al. | Optimal delivery strategies for nanoparticle-mediated mRNA delivery | |
| US20120269895A1 (en) | Dendritic pic micelles with bioactive proteins | |
| JP2021534162A5 (https=) | ||
| EP4644361A1 (en) | Lipid nanoparticle formulation comprising ionized lipids with branched structure, and use thereof | |
| EP4424701A1 (en) | Cyclic polypeptide carrier for efficient delivery of nucleic acid, and variants thereof | |
| WO2017068016A1 (en) | Methods and means for inducing an immune response |